These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2637943)

  • 1. Participation of the complement system in ischemia/reperfusion injury.
    Rubin B; Smith A; Romaschin A; Walker P
    Microcirc Endothelium Lymphatics; 1989; 5(3-5):207-21. PubMed ID: 2637943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microvascular effects of complement blockade with soluble recombinant CR1 on ischemia/reperfusion injury of skeletal muscle.
    Pemberton M; Anderson G; Vĕtvicka V; Justus DE; Ross GD
    J Immunol; 1993 Jun; 150(11):5104-13. PubMed ID: 8496606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent neutrophil (PMN) activation 24 hr after ischemia and reperfusion.
    Summers ST; Wyatt LE; Freischlag JA
    J Surg Res; 1994 Feb; 56(2):130-3. PubMed ID: 8121168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotective effects of selective inhibition of the two complement activation pathways in myocardial ischemia and reperfusion injury.
    Murohara T; Guo JP; Delyani JA; Lefer AM
    Methods Find Exp Clin Pharmacol; 1995 Oct; 17(8):499-507. PubMed ID: 8749222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation.
    De Vries B; Matthijsen RA; Wolfs TG; Van Bijnen AA; Heeringa P; Buurman WA
    Transplantation; 2003 Feb; 75(3):375-82. PubMed ID: 12589162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokines in ischemia and reperfusion.
    Frangogiannis NG
    Thromb Haemost; 2007 May; 97(5):738-47. PubMed ID: 17479184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgM binding to injured tissue precedes complement activation during skeletal muscle ischemia-reperfusion.
    Chan RK; Ding G; Verna N; Ibrahim S; Oakes S; Austen WG; Hechtman HB; Moore FD
    J Surg Res; 2004 Nov; 122(1):29-35. PubMed ID: 15522311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement activation and white cell sequestration in postischemic skeletal muscle.
    Rubin BB; Smith A; Liauw S; Isenman D; Romaschin AD; Walker PM
    Am J Physiol; 1990 Aug; 259(2 Pt 2):H525-31. PubMed ID: 2167024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of heparin in reducing skeletal muscle infarction in ischemia-reperfusion.
    Hobson RW; Neville R; Watanabe B; Canady J; Wright JG; Belkin M
    Microcirc Endothelium Lymphatics; 1989; 5(3-5):259-76. PubMed ID: 2637945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement, neutrophils and free radicals: mediators of reperfusion injury.
    Lucchesi BR
    Arzneimittelforschung; 1994 Mar; 44(3A):420-32. PubMed ID: 8185717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement-mediated ischemia-reperfusion injury: lessons learned from animal and clinical studies.
    Diepenhorst GM; van Gulik TM; Hack CE
    Ann Surg; 2009 Jun; 249(6):889-99. PubMed ID: 19474697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement activation during CAPD.
    Young GA; Kendall S; Brownjohn AM
    Nephrol Dial Transplant; 1993; 8(12):1372-5. PubMed ID: 8159307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischemia-reperfusion and cell membrane dysfunction.
    Perry MO; Fantini G
    Microcirc Endothelium Lymphatics; 1989; 5(3-5):241-58. PubMed ID: 2637944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The general and local response to injury related to complement activation.
    Heideman M; Gelin LE
    Acta Chir Scand Suppl; 1979; 489():215-23. PubMed ID: 291258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosstalk between thrombosis and inflammation in lung reperfusion injury.
    Farivar AS; Delgado MF; McCourtie AS; Barnes AD; Verrier ED; Mulligan MS
    Ann Thorac Surg; 2006 Mar; 81(3):1061-7. PubMed ID: 16488723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reperfusion injury to skeletal muscle affects primarily type II muscle fibers.
    Chan RK; Austen WG; Ibrahim S; Ding GY; Verna N; Hechtman HB; Moore FD
    J Surg Res; 2004 Nov; 122(1):54-60. PubMed ID: 15522315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hindlimb ischemia-reperfusion increases complement deposition and glycolysis.
    Wong MS; Lara TM; Kobzik L; Rounds JD; Robinson MK; Jacobs DO
    J Surg Res; 1999 Jul; 85(1):130-5. PubMed ID: 10383849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exogenous human recombinant interleukin-10 attenuates hindlimb ischemia-reperfusion injury.
    Engles RE; Huber TS; Zander DS; Hess PJ; Welborn MB; Moldawer LL; Seeger JM
    J Surg Res; 1997 May; 69(2):425-8. PubMed ID: 9224418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiinflammatory effects of soluble complement receptor type 1 promote rapid recovery of ischemia/reperfusion injury in rat small intestine.
    Eror AT; Stojadinovic A; Starnes BW; Makrides SC; Tsokos GC; Shea-Donohue T
    Clin Immunol; 1999 Feb; 90(2):266-75. PubMed ID: 10080839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of loss of human neutrophil chemotaxis following thermal injury.
    Nelson RD; Hasslen SR; Ahrenholz DH; Solem LD
    J Burn Care Rehabil; 1987; 8(6):496-502. PubMed ID: 3436972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.